DDIT4 and neoplasm: We found that REDD1 is essential for LDMC-mediated inhibition of tumor progression by attenuating tumor angiogenesis and lymphangiogenesis via reduced translation of Vegfr-2/3, providing new insights into the role of REDD1 in impairing TEC function.